The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Learning the best type of HIV prevention for those at highest risk can start with conversations about their options, writes ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

A model that can estimate the need for pre-exposure prophylaxis (PrEP) in the US can help to clarify use patterns to address ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

At the beginning of June, the Texas Department of State Health Services asked all programs funded by the CDC’s HIV Prevention ...

The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...